Christopher J Coughlin - Net Worth and Insider Trading
Christopher J Coughlin Net Worth
The estimated net worth of Christopher J Coughlin is at least $12 Million dollars as of 2024-10-19. Christopher J Coughlin is the Director of Alexion Pharmaceuticals Inc and owns about 26,333 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $5 Million. Christopher J Coughlin is the Director of Allergan PLC and owns about 16,431 shares of Allergan PLC (AGN) stock worth over $3 Million. Christopher J Coughlin is also the Exec. Vice President and CFO of Tyco International PLC and owns about 42,975 shares of Tyco International PLC (TYC) stock worth over $2 Million. Besides these, Christopher J Coughlin also holds Centene Corp (CNC) , Dun & Bradstreet Corp (Dun Bradstreet Corp) . Details can be seen in Christopher J Coughlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher J Coughlin has not made any transactions after 2024-05-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher J Coughlin
Christopher J Coughlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher J Coughlin owns 8 companies in total, including Prestige Consumer Healthcare Inc (PBH) , Alexion Pharmaceuticals Inc (ALXN) , and Karuna Therapeutics Inc (KRTX) among others .
Click here to see the complete history of Christopher J Coughlin’s form 4 insider trades.
Insider Ownership Summary of Christopher J Coughlin
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PBH | Prestige Consumer Healthcare Inc | 2020-08-04 | director |
ALXN | Alexion Pharmaceuticals Inc | 2020-05-14 | director |
KRTX | Karuna Therapeutics Inc | 2020-04-24 | director |
2016-03-02 | director | ||
2014-03-12 | director | ||
2007-06-29 | Exec. VP and CFO | ||
2003-06-16 | director & COO | ||
2024-05-14 | director |
Christopher J Coughlin Latest Holdings Summary
Christopher J Coughlin currently owns a total of 5 stocks. Among these stocks, Christopher J Coughlin owns 26,333 shares of Alexion Pharmaceuticals Inc (ALXN) as of April 30, 2018, with a value of $5 Million and a weighting of 40.3%. Christopher J Coughlin owns 16,431 shares of Allergan PLC (AGN) as of September 6, 2018, with a value of $3 Million and a weighting of 26.6%. Christopher J Coughlin also owns 42,975 shares of Tyco International PLC (TYC) as of February 21, 2006, with a value of $2 Million and a weighting of 16.43%. The other 2 stocks Centene Corp (CNC) , Dun & Bradstreet Corp (Dun Bradstreet Corp) have a combined weighting of 16.67% among all his current holdings.
Latest Holdings of Christopher J Coughlin
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALXN | Alexion Pharmaceuticals Inc | 2018-04-30 | 26,333 | 182.50 | 4,805,773 |
AGN | Allergan PLC | 2018-09-06 | 16,431 | 193.02 | 3,171,512 |
TYC | Tyco International PLC | 2006-02-21 | 42,975 | 45.59 | 1,959,230 |
CNC | Centene Corp | 2024-05-14 | 25,504 | 62.02 | 1,581,758 |
Dun Bradstreet Corp | Dun & Bradstreet Corp | 2015-11-06 | 15,857 | 25.65 | 406,732 |
Holding Weightings of Christopher J Coughlin
Christopher J Coughlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher J Coughlin has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the acquisition of 10,000 shares on April 30, 2018, which cost Christopher J Coughlin around $1 Million.
According to the SEC Form 4 filings, Christopher J Coughlin has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the acquisition of 10,000 shares on September 6, 2018, which cost Christopher J Coughlin around $2 Million.
According to the SEC Form 4 filings, Christopher J Coughlin has made a total of 0 transactions in Tyco International PLC (TYC) over the past 5 years. The most-recent trade in Tyco International PLC is the acquisition of 2,387 shares on February 21, 2006, which cost Christopher J Coughlin around $255,400.
More details on Christopher J Coughlin's insider transactions can be found in the Insider Trading History of Christopher J Coughlin table.Insider Trading History of Christopher J Coughlin
- 1
Christopher J Coughlin Trading Performance
GuruFocus tracks the stock performance after each of Christopher J Coughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher J Coughlin is 4.27%. GuruFocus also compares Christopher J Coughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher J Coughlin within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher J Coughlin's insider trading performs compared to the benchmark.
Performance of Christopher J Coughlin
Christopher J Coughlin Ownership Network
Christopher J Coughlin Owned Company Details
What does Prestige Consumer Healthcare Inc do?
Who are the key executives at Prestige Consumer Healthcare Inc?
Christopher J Coughlin is the director of Prestige Consumer Healthcare Inc. Other key executives at Prestige Consumer Healthcare Inc include Senior VP Quality & Regulatory Mary Beth Fritz , other: EVP & Marketing & Sales Adel Mekhail , and See Remarks William P'pool .
Prestige Consumer Healthcare Inc (PBH) Insider Trades Summary
Over the past 18 months, Christopher J Coughlin made no insider transaction in Prestige Consumer Healthcare Inc (PBH). Other recent insider transactions involving Prestige Consumer Healthcare Inc (PBH) include a net sale of 16,865 shares made by Mary Beth Fritz , a net sale of 49,937 shares made by Adel Mekhail , and a net sale of 85,313 shares made by Christine Sacco .
In summary, during the past 3 months, insiders sold 0 shares of Prestige Consumer Healthcare Inc (PBH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 210,934 shares of Prestige Consumer Healthcare Inc (PBH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 210,934 shares.
Prestige Consumer Healthcare Inc (PBH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prestige Consumer Healthcare Inc Insider Transactions
Christopher J Coughlin Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher J Coughlin. Currently GuruFocus does not have mailing address information for Christopher J Coughlin.